Dr. Prestia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Double Beach Rd
Branford, CT 06405Phone+1 203-315-7301
Education & Training
- Yale-New Haven Medical CenterFellowship, Hospice and Palliative Medicine, 2021 - 2022
- HCA Healthcare/Mercer University School of Medicine/Memorial Health University Medical CenterChief Residency, Family Medicine, 2020 - 2021
- HCA Healthcare/Mercer University School of Medicine/Memorial Health University Medical CenterResidency, Family Medicine, 2018 - 2021
- Campbell University School of Osteopathic MedicineClass of 2018, DO
- College of William & MaryBA, History, 2010 - 2014
Certifications & Licensure
- CT State License 2021 - 2025
- GA State License 2019 - 2025
- American Board of Family Medicine Family Medicine
- American Board of Family Medicine Hospice and Palliative Medicine
Publications & Presentations
PubMed
- 2 citationsA Retrospective Look at North Carolina's Efforts to Reduce Infant Mortality.Brett M Prestia, Jeremy A. Rhodes, Randall W Williams
North Carolina Medical Journal. 2016-11-01 - 1 citationsUtilization of Patient-Controlled Analgesia Reduces Length of Stay of Sickle Cell Crisis Hospitalizations.Brett M Prestia, Talha Ramzan, Catherine Waldron, Ameer Malik, Robert M Pallay
HCA Healthcare Journal of Medicine. 2021-01-01 - Factors Associated With Inpatient Hospice Utilization Among Hospitalized Decedents With Comfort Measures Only Status.Dmitry Kozhevnikov, Hieronimus Loho, Brett Prestia
Journal of Palliative Medicine. 2023-08-01
Journal Articles
- Utilization of Patient-Controlled Analgesia Reduces Length of Stay of Sickle Cell Crisis HospitalizationsPrestia BM, HCA Journal of Medicine, 10/2021
- Are pneumatic compression devices as effective as anticoagulants for VTE prophylaxis after joint replacement surgery?Prestia, Sineath, Evidence-Based Practice, 6/2020
- Sacubitril/valsartan might be associated with reduced risk of cardiovascular mortality or hospitalization for heart failure compared to valsartan alone in adults with ...Prestia, Sineath, DynaMed, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: